These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 12942453

  • 1. An evaluation of long-term outcomes after liver transplantation for cryptogenic cirrhosis.
    Heneghan MA, Zolfino T, Muiesan P, Portmann BC, Rela M, Heaton ND, O'grady JG.
    Liver Transpl; 2003 Sep; 9(9):921-8. PubMed ID: 12942453
    [Abstract] [Full Text] [Related]

  • 2. Long-term outcome of hepatitis C infection after liver transplantation.
    Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, Maertens G, Williams R.
    N Engl J Med; 1996 Mar 28; 334(13):815-20. PubMed ID: 8596547
    [Abstract] [Full Text] [Related]

  • 3. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
    Rosen HR, Shackleton CR, Higa L, Gralnek IM, Farmer DA, McDiarmid SV, Holt C, Lewin KJ, Busuttil RW, Martin P.
    Am J Gastroenterol; 1997 Sep 28; 92(9):1453-7. PubMed ID: 9317061
    [Abstract] [Full Text] [Related]

  • 4. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
    Prieto M, Berenguer M, Rayón JM, Córdoba J, Argüello L, Carrasco D, García-Herola A, Olaso V, De Juan M, Gobernado M, Mir J, Berenguer J.
    Hepatology; 1999 Jan 28; 29(1):250-6. PubMed ID: 9862874
    [Abstract] [Full Text] [Related]

  • 5. Liver transplantation and hepatitis C virus. Results in a Spanish center since 1989.
    Loinaz C, Lumbreras C, Moreno E, Colina F, Fuertes A, Gómez R, Jiménez C, González-Pinto I, García I, Rojas J, Bellorín C.
    Hepatogastroenterology; 2001 Jan 28; 48(41):1435-42. PubMed ID: 11677981
    [Abstract] [Full Text] [Related]

  • 6. Clinical outcomes of living donor liver transplantation for hepatitis C virus (HCV)-positive patients.
    Takada Y, Haga H, Ito T, Nabeshima M, Ogawa K, Kasahara M, Oike F, Ueda M, Egawa H, Tanaka K.
    Transplantation; 2006 Feb 15; 81(3):350-4. PubMed ID: 16477219
    [Abstract] [Full Text] [Related]

  • 7. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.
    Briceño J, Ciria R, Pleguezuelo M, de la Mata M, Muntané J, Naranjo A, Sánchez-Hidalgo J, Marchal T, Rufián S, López-Cillero P.
    Liver Transpl; 2009 Jan 15; 15(1):37-48. PubMed ID: 19109846
    [Abstract] [Full Text] [Related]

  • 8. Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation.
    Shiffman ML, Stravitz RT, Contos MJ, Mills AS, Sterling RK, Luketic VA, Sanyal AJ, Cotterell A, Maluf D, Posner MP, Fisher RA.
    Liver Transpl; 2004 Oct 15; 10(10):1248-55. PubMed ID: 15376308
    [Abstract] [Full Text] [Related]

  • 9. The impact of acute alcoholic hepatitis in the explanted recipient liver on outcome after liver transplantation.
    Wells JT, Said A, Agni R, Tome S, Hughes S, Dureja P, Lucey MR.
    Liver Transpl; 2007 Dec 15; 13(12):1728-35. PubMed ID: 18044757
    [Abstract] [Full Text] [Related]

  • 10. Outcome after orthotopic liver transplantation in five HIV-infected patients with virus hepatitis-induced cirrhosis.
    Radecke K, Frühauf NR, Miller M, Ross B, Köditz R, Malagó M, Broelsch CE, Gerken G, Treichel U.
    Liver Int; 2005 Feb 15; 25(1):101-8. PubMed ID: 15698406
    [Abstract] [Full Text] [Related]

  • 11. Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up.
    Neumann UP, Berg T, Bahra M, Puhl G, Guckelberger O, Langrehr JM, Neuhaus P.
    Transplantation; 2004 Jan 27; 77(2):226-31. PubMed ID: 14742986
    [Abstract] [Full Text] [Related]

  • 12. Severe recurrent hepatitis C after liver retransplantation for hepatitis C virus-related graft cirrhosis.
    Berenguer M, Prieto M, Palau A, Rayón JM, Carrasco D, Juan FS, López-Labrador FX, Moreno R, Mir J, Berenguer J.
    Liver Transpl; 2003 Mar 27; 9(3):228-35. PubMed ID: 12619018
    [Abstract] [Full Text] [Related]

  • 13. Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C.
    Machicao VI, Bonatti H, Krishna M, Aqel BA, Lukens FJ, Nguyen JH, Rosser BG, Satyanarayana R, Grewal HP, Hewitt WR, Harnois DM, Crook JE, Steers JL, Dickson RC.
    Transplantation; 2004 Jan 15; 77(1):84-92. PubMed ID: 14724440
    [Abstract] [Full Text] [Related]

  • 14. Progression of liver fibrosis in patients with chronic hepatitis C after orthotopic liver transplantation.
    Chopra KB, Demetris AJ, Blakolmer K, Dvorchik I, Laskus T, Wang LF, Araya VR, Dodson F, Fung JJ, Rakela J, Vargas HE.
    Transplantation; 2003 Nov 27; 76(10):1487-91. PubMed ID: 14657691
    [Abstract] [Full Text] [Related]

  • 15. Minimal but significant improvement in survival for non-hepatitis C-related adult liver transplant patients beyond the one-year posttransplant mark.
    McCaughan GW, Shackel NA, Strasser SI, Dilworth P, Tang P, Australian and New Zealand Liver Transplant Study Group.
    Liver Transpl; 2010 Feb 27; 16(2):130-7. PubMed ID: 20104480
    [Abstract] [Full Text] [Related]

  • 16. Fibrosis progression after liver transplantation in patients with recurrent hepatitis C.
    Neumann UP, Berg T, Bahra M, Seehofer D, Langrehr JM, Neuhaus R, Radke C, Neuhaus P.
    J Hepatol; 2004 Nov 27; 41(5):830-6. PubMed ID: 15519657
    [Abstract] [Full Text] [Related]

  • 17. Histological and clinical outcome after liver transplantation for hepatitis C.
    Shuhart MC, Bronner MP, Gretch DR, Thomassen LV, Wartelle CF, Tateyama H, Emerson SS, Perkins JD, Carithers RL.
    Hepatology; 1997 Dec 27; 26(6):1646-52. PubMed ID: 9398011
    [Abstract] [Full Text] [Related]

  • 18. Outcomes of hepatitis C- and hepatitis B core antibody-positive grafts in orthotopic liver transplantation.
    Saab S, Chang AJ, Comulada S, Geevarghese SK, Anselmo RD, Durazo F, Han S, Farmer DG, Yersiz H, Goldstein LI, Ghobrial RM, Busuttil RW.
    Liver Transpl; 2003 Oct 27; 9(10):1053-61. PubMed ID: 14526400
    [Abstract] [Full Text] [Related]

  • 19. Liver transplantation for HCV-associated liver cirrhosis: predictors of outcomes in a population with significant genotype 3 and 4 distribution.
    Zekry A, Whiting P, Crawford DH, Angus PW, Jeffrey GP, Padbury RT, Gane EJ, McCaughan GW, Australian and New Zealand Liver Transplant Clinical Study Group.
    Liver Transpl; 2003 Apr 27; 9(4):339-47. PubMed ID: 12682883
    [Abstract] [Full Text] [Related]

  • 20. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.
    Burra P, Loreno M, Russo FP, Germani G, Galligioni A, Senzolo M, Cillo U, Zanus G, Fagiuoli S, Rugge M.
    Liver Transpl; 2009 Jun 27; 15(6):619-28. PubMed ID: 19479805
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.